← Back
▼ SELL

$ Value

$2.6M

Shares

2,759

Price

$941

Filed

Nov 6

Insider

Name

LILLY ENDOWMENT INC

Title

CIK

0000316011

Roles

10% Owner

Transaction Details

Transaction Date

2025-11-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

93,787,248

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $910.90 to $911.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23), (24), (25), (26), (27), (28), and (29) to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $913.36 to $914.31, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $914.59 to $915.46, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.76 to $917.38, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $920.99 to $921.98, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $921.99 to $922.985, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $922.99 to $923.97, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $923.99 to $924.835, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.77 to $926.71, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.77 to $927.76, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.78 to $928.765, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.78 to $929.77, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.78 to $930.77, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.79 to $931.77, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.80 to $932.7975, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $932.80 to $933.78, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.84 to $934.76, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.84 to $935.78, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.00 to $936.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.00 to $937.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.00 to $938.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.00 to $939.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $940.00 to $940.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.03 to $941.695, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.05 to $942.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $943.09 to $944.06, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $944.10 to $945.09, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $945.13 to $946.125, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $946.14 to $947.06, inclusive.

Filing Info

Accession No.

0000316011-25-000054

Form Type

4

Issuer CIK

0000059478

LILLY ENDOWMENT INC's History

Date Ticker Type Value
2026-01-07 LLY $971K
2026-01-07 LLY $8.4M
2026-01-07 LLY $1.2M
2026-01-07 LLY $1.0M
2026-01-07 LLY $3.9M
2026-01-07 LLY $1.3M
2026-01-07 LLY $1.2M
2026-01-07 LLY $1.4M
2026-01-07 LLY $460K
2026-01-07 LLY $520K

Other Insiders at LLY (90d)

Insider Bought Sold Last
Sulzberger Gabrielle 2026-04-20
Alvarez Ralph 2026-04-20
Fyrwald J Erik 2026-04-20
LUCIANO JUAN R 2026-04-20
Ricks David A
President, Chair, and CEO
2026-02-09
Zakrowski Donald A
SVP, Finance, & CAO
2026-02-16
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
2026-02-09
Hakim Anat
EVP, GC & Secretary
2026-02-09
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
2026-02-09
Montarce Lucas
EVP & CFO
2026-02-16
Jonsson Patrik
EVP & President, LLY Int'l
2026-02-09
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab
2026-02-09
Rau Diogo
EVP & CIDO
2026-02-09
Hernandez Edgardo
EVP & Pres., Mfg. Operations
2026-02-09
Dozier Eric
EVP, Chief People Officer
2026-02-19
Custer Kenneth L.
EVP & President, Card Met Hlth
2026-02-16
Brown Adrienne S
EVP, President LLY Imm
2026-02-16